Stryker Corporation
Stryker Corporation (SYK) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · SYK · as of Jun 8, 2026
Key Statistics
Explore Stryker Corporation Data
syk stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 51 · Buy rate: 72.5%
The SYK analyst consensus is Buy, based on ratings from 51 Wall Street analysts over the past 3 months. The average 12-month price target is $387.46, representing +26.76% upside from the current price of $305.66.
Competitors & Peers
syk competitorsSYK
AMGN
BSX
DHR
GILD
HCAStock Performance
Full HistoryAbout Stryker Corporation
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment pro…
what is stryker corporation · syk stock overview · stryker corporation company profile · who is stryker corporation ceo · syk NYSE · stryker corporation headquarters · stryker corporation business segments
About Stock Overview & Key Data
Stryker Corporation (SYK) is a Healthcare company in the Medical - Devices industry, listed on NYSE since Mar 17, 1980. As of the latest trading session, SYK stock price is $305.66, with a market capitalization of $117.2B. The stock has returned -20.04% over the past 12 months and -13.03% year-to-date.
According to 51 Wall Street analysts, the consensus rating for Stryker Corporation stock is Buy, with an average 12-month price target of $387.46. In fiscal year 2025, Stryker Corporation reported revenue of $25.1B and net income of $3.2B. For detailed data — including Stryker Corporation revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Stryker Corporation (SYK) stock price is $305.66. The stock is traded on NYSE under the ticker symbol SYK. The 52-week range is $281.00 – $404.87.